Fermenta Biotech Limited (BOM:506414)

Fermenta Biotech Revenue

Fermenta Biotech had revenue of 1.36B INR in the quarter ending September 30, 2026, with 4.25% growth. This brings the company's total for the last twelve months to 5.07B, down -9.97% year-over-year. In the fiscal year ending March 31, 2026, Fermenta Biotech had annual revenue of 5.25B with 11.92% growth. That makes Fermenta Biotech the 27,418th largest company in the world by revenue and 1,802nd in India.

• Revenue (ttm): 5.07B
• Revenue Growth: -9.97%
• P/S Ratio: 2.53
• Revenue / Employee: 8.04M
• Employees: 630
• Market Cap: 12.82B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Bulk Drugs/chemicals 5.15B 94.0%
• Unallocated 235.80M 4.3%
• Property 95.13M 1.7%

By Geography

Chart

• India 2.15B 39.3%
• Europe 1.62B 29.5%
• Others Countries 976.82M 17.8%
• USA 731.22M 13.3%

Fiscal year ended Mar 31, 2026 See the full Fermenta Biotech breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	5.25B	559.52M	11.92%
Mar 31, 2025	4.69B	1.34B	39.87%
Mar 31, 2024	3.36B	-142.79M	-4.08%
Mar 31, 2023	3.50B	-485.75M	-12.19%
Mar 31, 2022	3.99B	212.27M	5.63%

Data Source: S&P Global Market Intelligence Last updated: Nov 5, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 6, 2026

Data Sources Report a data error